A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Trial details
- Registry ID
- NCT04578548
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)NCT04578548 | LKFT | Phase 2 | Terminated | 2022-12-14Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |